Patients in EuroSIDA starting at least 1 new antiretroviral drug with CD4<350 cells/μl and viral load (VL)>500 copies/mL were followed-up from the first day of VL< = 50 copies/ml until a new fatal/non-fatal non-AIDS/AIDS event. The gene discussed is CD4; the disease is AIDS.